Hyperparathyroidism

• EMA approval · 2026-08-18
  EMA Authorised: Parsabiv (etelcalcetide hydrochloride) — Amgen Europe B.V.

  Parsabiv (etelcalcetide hydrochloride) has been authorized by EMA for secondary hyperparathyroidism.

• CLINICAL_TRIALS trial_result · 2026-07-02
  Clinical Trial Results: Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis [Phase 3]

  Phase 3 trial evaluating safety and efficacy of Hectorol in pediatric CKD stage 3-4 with secondary hyperparathyroidism; study terminated wit…

• CLINICAL_TRIALS trial_result · 2026-06-15
  Clinical Trial Results: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) [Phase 3]

  Phase 3 study evaluating safety, efficacy, and pharmacokinetics of paricalcitol for pediatric secondary hyperparathyroidism in stage 5 chron…

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors [Phase 2, Phase 3]

  This clinical trial update evaluates the accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT imaging for localizing parathyroid tu…

• CLINICAL_TRIALS research · 2026-04-09
  Clinical Trial Update: Natural History Study of Parathyroid Disorders

  This clinical trial update describes a natural history study of parathyroid disorders that is currently recruiting.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2026-04-08
  Clinical Trial Update: Surgery for Primary Hyperparathyroidism (pHPT) in Patients Older Than 65 Years Compared With Follow-up [NA]

  This clinical trial update notes the completion of a study comparing surgery to follow-up for primary hyperparathyroidism in patients older …

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Parathyroid Tumor Clonal Status

  This entry reports a clinical trial (NCT05997810) investigating clonal status in parathyroid tumors, currently recruiting.

• EMA approval · 2026-03-31
  EMA Authorised: Cinacalcet Accordpharma (cinacalcet hydrochloride) — Accord Healthcare S.L.U.

  The EMA authorised Cinacalcet Accordpharma (cinacalcet hydrochloride) by Accord Healthcare S.L.U. for the treatment of hyperparathyroidism.

• CLINICAL_TRIALS research · 2026-03-30
  Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants [Phase 2]

  This document outlines a Phase 2 pharmacokinetics, pharmacodynamics, safety and tolerability evaluation of CTAP101 extended-release capsules…

• FDA approval · 2026-03-23
  FDA Approved: CINACALCET — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for cinacalcet from Aurobindo Pharma Limited, allowing a generic version to be marketed.

• CLINICAL_TRIALS trial_result · 2026-03-23
  Clinical Trial Update: A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism [Phase 1]

  This document reports the completion of a Phase 1 mass balance study of [14C] SHR6508 in Chinese hemodialysis patients with secondary hyperp…

• CLINICAL_TRIALS research · 2026-03-23
  Clinical Trial Update: A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis [Phase 3]

  This clinical trial update notes a Phase 3 study of etelcalcetide in children with secondary hyperparathyroidism receiving hemodialysis, and…

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism [NA]

  This clinical trial update describes a study evaluating patient navigation to improve access to surgical treatment for primary hyperparathyr…

• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis [Phase 3]

  Phase 3 clinical trial evaluating etelcalcetide in pediatric patients with secondary hyperparathyroidism due to chronic kidney disease on he…

• CLINICAL_TRIALS research · 2026-02-17
  Clinical Trial Update: Parathyroidectomy After Kidney Transplantation [NA]

  Clinical trial update about a study on parathyroidectomy for hyperparathyroidism in kidney transplant recipients, currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-02-06
  Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism [Phase 2]

  Phase 2 clinical trial evaluating MT1013 for safety, tolerability, and efficacy in patients with secondary hyperparathyroidism due to chroni…

• CLINICAL_TRIALS research · 2026-02-05
  Clinical Trial Update: Aldosterone Variations in Patients With Primary Hyperparathyroidism After Surgery

  A clinical trial evaluating aldosterone variations in patients with primary hyperparathyroidism after parathyroid surgery; the study is not …

• CLINICAL_TRIALS trial_result · 2026-02-05
  Clinical Trial Update: MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease [Phase 2]

  Phase 2 trial of MT1013 Injection for secondary hyperparathyroidism in chronic kidney disease patients on hemodialysis has completed.

• CLINICAL_TRIALS research · 2026-01-30
  Clinical Trial Update: Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases

  Ongoing clinical trial evaluating PET/CT imaging of the amino acid transporter system (AATS) in AATS-related diseases; currently recruiting.

• CLINICAL_TRIALS trial_result · 2026-01-14
  Clinical Trial Update: Upfront Ultrasound for Preoperative Localization in Primary Hyperparathyroidism

  This trial evaluated upfront ultrasound localization to guide preoperative planning for parathyroid surgery in primary hyperparathyroidism a…

• CLINICAL_TRIALS other · 2025-12-16
  Clinical Trial Update: A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism [Phase 1]

  Phase 1 mass-balance study of [14C] MT1013 in hemodialysis patients with secondary hyperparathyroidism is currently recruiting.

• CLINICAL_TRIALS trial_result · 2025-12-15
  Clinical Trial Update: Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy [NA]

  This completed clinical trial evaluates near-infrared autofluorescence for identifying parathyroid glands during parathyroidectomy, with res…

• CLINICAL_TRIALS trial_result · 2025-12-12
  Clinical Trial Update: The Trial of SHR6508 in Secondary Hyperparathyroidism [Phase 3]

  A Phase 3 trial of SHR6508 for secondary hyperparathyroidism has completed.

• CLINICAL_TRIALS trial_result · 2025-12-04
  Clinical Trial Update: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) [Phase 3]

  Phase 3 clinical trial assessing safety, efficacy and pharmacokinetics of paricalcitol for secondary hyperparathyroidism in pediatric patien…

• CLINICAL_TRIALS research · 2025-11-21
  Clinical Trial Update: Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors

  A clinical trial entry describing a study that profiles parathyroid tumors using molecular and immunohistochemical techniques.